Clinical Trials Directory

Trials / Sponsors / Eben Rosenthal

Eben Rosenthal

Academic / Other · 9 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
WithdrawnPilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
Solid Tumor Cancer, Solid Tumor Malignancy, Cancer
EARLY_Phase 12027-01-01
Not Yet RecruitingPilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During
Meningioma, Glioblastoma, Acoustic Neuroma
EARLY_Phase 12026-05-02
Not Yet RecruitingWindow Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Brain Cancer, HGG, Glioma
EARLY_Phase 12026-03-30
Recruiting(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinom
Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
Phase 12023-05-09
CompletedPanitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastati
Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Head and Neck Cancer
Phase 22019-08-01
TerminatedCetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Brain Neoplasm, Malignant Glioma
Phase 1 / Phase 22016-10-01
CompletedPanitumumab IRDye800 Optical Imaging Study
Head and Neck Cancer
Phase 12016-08-01
TerminatedCetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery
Pancreatic Adenocarcinoma
Phase 22016-07-01
TerminatedCetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Head and Neck Cancer
Phase 12015-11-01